Loading clinical trials...
Loading clinical trials...
A Phase I, Double-blind, Parallel, Randomised and Placebo-controlled Trial Investigating the Safety and Immunogenicity of a Chlamydia Vaccine, CTH522, in Healthy Adults
Conditions
Interventions
CTH522-CAF01 IM
CTH522-CAF09b IM
+3 more
Locations
1
United Kingdom
NIHR Imperial Center for Translational and Experimental Medicine
London, United Kingdom
Start Date
February 17, 2020
Primary Completion Date
February 22, 2022
Completion Date
February 22, 2022
Last Updated
August 22, 2024
NCT07322302
NCT06891417
NCT07458802
NCT00207454
NCT04955717
NCT05581160
Lead Sponsor
Statens Serum Institut
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions